Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01726114 · ClinicalTrials.gov registry record · NA

A Clinical Study of the C8 MediSensors Optical Glucose Monitor™

A NA study of Diabetes Mellitus, sponsored by C8 MediSensors.

Completed
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT01726114 is a NA study of Diabetes Mellitus that has completed, run by C8 MediSensors. The registered enrollment target is 86 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01726114, a NA study of Diabetes Mellitus, has completed, sponsored by C8 MediSensors.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare glucose measurements from the C8 MediSensors non-invasive Optical Glucose Monitor™ System to blood glucose measurements from the Yellow Springs Instrument(YSI) blood glucose analyzer.

Conditions Studied

Interventions

  • DEVICE Non-invasive Optical Glucose Monitor™
  • DEVICE YSI blood glucose analyzer

Study Locations (1)

California

  • C8 MediSensors, Inc. - San Jose

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2012-06
Est. Completion 2013-03
Phase NA

Sponsor

C8 MediSensors

1 total trials

What the Registry Record Tells You About NCT01726114

The ClinicalTrials.gov registry entry for NCT01726114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The listed sponsor is C8 MediSensors, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Non-invasive Optical Glucose Monitor™ is the first listed.

NCT01726114 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01726114 about?

NCT01726114 is a clinical study titled "A Clinical Study of the C8 MediSensors Optical Glucose Monitor™". The purpose of this study is to compare glucose measurements from the C8 MediSensors non-invasive Optical Glucose Monitor™ System to blood glucose measurements from the Yellow Springs Instrument(YSI) blood glucose analyzer.

What is the current status of trial NCT01726114?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2012-06. Estimated completion is 2013-03.

What conditions does trial NCT01726114 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT01726114?

The interventions under investigation include: Non-invasive Optical Glucose Monitor™ (DEVICE), YSI blood glucose analyzer (DEVICE).

Who is sponsoring clinical trial NCT01726114?

This trial is sponsored by C8 MediSensors, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01726114 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.